EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	103.78M
Revenue (ttm)	66.87M
Net Income (ttm)	6.73M
Shares Out	47.17M
EPS (ttm)	0.15
PE Ratio	15.12
Forward PE	10.95
Dividend	0.04 (1.82%)
Ex-Dividend Date	May 16, 2025

Volume	158,478
Average Volume	110,007
Open	2.230
Previous Close	2.190
Day's Range	2.130 - 2.260
52-Week Range	1.290 - 4.970
Beta	0.53
RSI	45.99
Earnings Date	Aug 28, 2025

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.